Glenmark gets FDA's blessing for two generics
Glenmark Pharmaceuticals has received the Food and Drug Administration’s nod for for fluocinolone acetonide oil, 0.01%, ear drops
The product is a generic version of Hill Dermaceuticals’ DermOtic Oil, 0.01% ear drops.
The product had a market value of approximately $18.1 million for the 12 month period ending October 2018, according to IQVIA data.
Glenmark also received the FDA green light for hydrocortisone valerate ointment, 0.2%.
The product is the generic version of Sun Pharmaceutical’s Westcort ointment, 0.2%.
Westcort ointment, 0.2% had a market value of about $11.1 million for the 12 month period ending October 2018, according to IQVIA data.
The product is a generic version of Hill Dermaceuticals’ DermOtic Oil, 0.01% ear drops.
The product had a market value of approximately $18.1 million for the 12 month period ending October 2018, according to IQVIA data.
Glenmark also received the FDA green light for hydrocortisone valerate ointment, 0.2%.
The product is the generic version of Sun Pharmaceutical’s Westcort ointment, 0.2%.
Westcort ointment, 0.2% had a market value of about $11.1 million for the 12 month period ending October 2018, according to IQVIA data.